Two studies concerning post-licensure use of the meningococcal group B vaccine published today in the New England Journal of Medicine show the vaccine prevents disease among recipients, but it does not affect pharyngeal carriage of the bacterium Neisseria meningitidis on a population level.

The studies are based on data collected from the United Kingdom and Australia.

Filling in previous data gaps


Credit: CDC

Read more at CIDRAP…

See also:

Jan 23 N Engl J Med UK study

Jan 23 N Engl J Med Australia study

Jan 23 N Engl J Med commentary

Jan 23 PHE press release

Jan 22 University of Adelaide press release